IU researchers discover “Humpty-Dumpty” water-based mechanism of human sex reversal at edge of developmental ambiguity
Researchers from Indiana University School of Medicine have discovered a molecular “clamping” mechanism within a male-specific protein-DNA complex whose mutation causes sex reversal.
IU School of Medicine | Dec 22, 2022
First patient enrolls in IU-led clinical trial to study treatment for acute heart attack complications
A groundbreaking new clinical trial to determine the effectiveness of a new treatment for patients with acute heart attack is now underway at Indiana University ...
IU School of Medicine | Dec 22, 2022
IU School of Medicine researchers publish findings which could help prevent side effects for breast cancer patients
Researchers at IU School of Medicine are learning more about ways to prevent serious side effects from chemotherapy used to treat breast cancer patients.
IU School of Medicine | Dec 20, 2022
Neuroscience researcher Debomoy Lahiri, PhD, elected to National Academy of Inventors
Indiana University School of Medicine distinguished professor Debomoy Lahiri, PhD, has been named a 2022 fellow of the National Academy of Inventors – the highest ...
IU School of Medicine | Dec 16, 2022
IU School of Medicine launches state’s first andrology and sexual medicine fellowship
Indiana University School of Medicine Department of Urology is now accepting applications for a new fellowship focused on andrology and male sexual and reproductive medicine. ...
IU School of Medicine | Dec 14, 2022
New $3.5 million grant to aid in identification of new neurodegenerative diseases
Researchers from Indiana University School of Medicine and the University of Toronto have been awarded a five-year, $3.5 million grant from the National Institute on ...
IU School of Medicine | Dec 08, 2022
New Walther Professor in Supportive Oncology to focus on music therapy for cancer patients
Indiana University School of Medicine has named Sheri Robb, PhD, a Walther Professor of Supportive Oncology.
IU School of Medicine | Dec 05, 2022
IU researchers study relationship between epilepsy drug and Alzheimer’s disease
Researchers from an Indiana University School of Medicine-led consortium of Alzheimer’s disease experts are studying how an anti-seizure drug used to treat epilepsy in children ...
IU School of Medicine | Nov 30, 2022
IU research contributes to first FDA-approved drug to delay onset of type 1 diabetes
Researchers at Indiana University School of Medicine are celebrating Federal Drug Administration approval of teplizumab, a new immunotherapy drug that delays the onset of type ...
IU School of Medicine | Nov 21, 2022
IU researchers identify protein that contributes to tau neurotoxicity in Alzheimer’s disease
Researchers from Indiana University School of Medicine have identified a protein that interacts and enhances the spread of neurotoxic species of tau—which is primarily found ...